NovaBay Pharmaceuticals Inc (NBY)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-15 | 2025-04-08 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
300
+0.0%
0.47USD 140 |
300 +0.0% | 0.47 | USD 140 | |
| 2025-04-15 | 2025-04-04 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
4,538
+0.4%
0.52USD 2,367 |
4,538 +0.4% | 0.52 | USD 2,367 | |
| 2025-04-15 | 2025-04-03 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
22,976
+2.3%
0.56USD 12,929 |
22,976 +2.3% | 0.56 | USD 12,929 | |
| 2025-04-15 | 2025-04-02 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
917
+0.1%
0.58USD 532 |
917 +0.1% | 0.58 | USD 532 | |
| 2025-04-15 | 2025-04-01 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
19,915
+2.0%
0.59USD 11,650 |
19,915 +2.0% | 0.59 | USD 11,650 | |
| 2025-04-15 | 2025-03-31 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
21,654
+2.3%
0.59USD 12,776 |
21,654 +2.3% | 0.59 | USD 12,776 | |
| 2025-04-15 | 2025-03-28 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
49,400
+5.5%
0.61USD 30,253 |
49,400 +5.5% | 0.61 | USD 30,253 | |
| 2025-04-15 | 2025-03-27 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
600
+0.1%
0.61USD 365 |
600 +0.1% | 0.61 | USD 365 | |
| 2025-04-15 | 2025-03-27 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
18,504
+2.1%
0.62USD 11,380 |
18,504 +2.1% | 0.62 | USD 11,380 | |
| 2025-04-15 | 2025-03-26 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
13,292
+1.5%
0.61USD 8,095 |
13,292 +1.5% | 0.61 | USD 8,095 | |
| 2025-04-15 | 2025-03-25 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
22,635
+2.7%
0.61USD 13,807 |
22,635 +2.7% | 0.61 | USD 13,807 | |
| 2025-04-15 | 2025-03-24 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
100
+0.0%
0.61USD 61 |
100 +0.0% | 0.61 | USD 61 | |
| 2025-04-15 | 2025-03-21 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
6,372
+0.8%
0.61USD 3,855 |
6,372 +0.8% | 0.61 | USD 3,855 | |
| 2025-04-15 | 2025-03-20 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
5,320
+0.6%
0.61USD 3,271 |
5,320 +0.6% | 0.61 | USD 3,271 | |
| 2025-04-15 | 2025-03-19 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
1,500
+0.2%
0.60USD 904 |
1,500 +0.2% | 0.60 | USD 904 | |
| 2025-04-15 | 2025-03-18 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
14,000
+1.7%
0.63USD 8,820 |
14,000 +1.7% | 0.63 | USD 8,820 | |
| 2025-04-15 | 2025-03-18 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
10,000
+1.2%
0.63USD 6,300 |
10,000 +1.2% | 0.63 | USD 6,300 | |
| 2025-04-15 | 2025-03-14 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
25,511
+3.3%
0.63USD 16,072 |
25,511 +3.3% | 0.63 | USD 16,072 | |
| 2025-04-15 | 2025-03-13 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
34
+0.0%
0.64USD 22 |
34 +0.0% | 0.64 | USD 22 | |
| 2025-04-15 | 2025-03-12 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
11,837
+1.5%
0.62USD 7,370 |
11,837 +1.5% | 0.62 | USD 7,370 | |
| 2025-04-15 | 2025-03-11 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
2,148
+0.3%
0.58USD 1,246 |
2,148 +0.3% | 0.58 | USD 1,246 | |
| 2025-04-15 | 2025-03-10 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
14,645
+1.9%
0.58USD 8,494 |
14,645 +1.9% | 0.58 | USD 8,494 | |
| 2025-04-15 | 2025-03-07 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
102
+0.0%
0.55USD 56 |
102 +0.0% | 0.55 | USD 56 | |
| 2025-04-15 | 2025-03-04 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
4,000
+0.5%
0.58USD 2,314 |
4,000 +0.5% | 0.58 | USD 2,314 | |
| 2025-04-15 | 2025-02-28 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
13,108
+1.8%
0.60USD 7,891 |
13,108 +1.8% | 0.60 | USD 7,891 | |
| 2025-04-15 | 2025-02-27 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
385
+0.1%
0.61USD 235 |
385 +0.1% | 0.61 | USD 235 | |
| 2025-04-15 | 2025-02-26 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
6,302
+0.9%
0.61USD 3,844 |
6,302 +0.9% | 0.61 | USD 3,844 | |
| 2025-04-15 | 2025-02-25 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
25,033
+3.5%
0.62USD 15,518 |
25,033 +3.5% | 0.62 | USD 15,518 | |
| 2025-04-15 | 2025-02-24 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
450
+0.1%
0.62USD 279 |
450 +0.1% | 0.62 | USD 279 | |
| 2025-04-15 | 2025-02-20 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
1,836
+0.3%
0.63USD 1,157 |
1,836 +0.3% | 0.63 | USD 1,157 | |
| 2025-04-15 | 2025-02-19 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
49,664
+7.6%
0.67USD 33,349 |
49,664 +7.6% | 0.67 | USD 33,349 | |
| 2025-04-15 | 2025-02-18 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
3,222
+0.5%
0.66USD 2,127 |
3,222 +0.5% | 0.66 | USD 2,127 | |
| 2025-04-15 | 2025-02-04 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
26,718
+4.3%
0.64USD 16,966 |
26,718 +4.3% | 0.64 | USD 16,966 | |
| 2025-04-15 | 2025-02-03 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
2,597
+0.4%
0.64USD 1,649 |
2,597 +0.4% | 0.64 | USD 1,649 | |
| 2025-04-15 | 2025-01-31 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
70,685
+12.9%
0.65USD 45,825 |
70,685 +12.9% | 0.65 | USD 45,825 | |
| 2025-04-15 | 2025-01-27 | B Purchase |
POPLAR POINT CAPITAL PARTNERS LP Large shareholder |
31,703
+6.1%
0.69USD 21,875 |
31,703 +6.1% | 0.69 | USD 21,875 | |
| 2022-12-07 | 2022-12-06 | S Sale |
President, DERMAdoctor, LLC Officer |
1
1.81USD 2 |
1 | 1.81 | USD 2 | |
| 2022-12-07 | 2022-12-06 | S Sale |
Chief Product Officer Officer |
1
1.81USD 2 |
1 | 1.81 | USD 2 | |
| 2022-11-23 | 2022-11-21 | S Sale |
President, DERMAdoctor, LLC Officer |
5,960
-100.0%
2.10USD 12,545 |
5,960 -100.0% | 2.10 | USD 12,545 | |
| 2022-11-23 | 2022-11-21 | S Sale |
Chief Product Officer Executive Director |
5,960
-100.0%
2.10USD 12,545 |
5,960 -100.0% | 2.10 | USD 12,545 | |
| 2022-09-16 | 2022-09-14 | B Purchase |
CEO, GC and Director Executive Director |
10,000
+13.7%
0.15USD 1,500 |
10,000 +13.7% | 0.15 | USD 1,500 | |
| 2022-09-16 | 2022-09-14 | S Sale |
President, DERMAdoctor, LLC Officer |
291,368
-58.3%
0.16USD 46,094 |
291,368 -58.3% | 0.16 | USD 46,094 | |
| 2022-09-16 | 2022-09-14 | S Sale |
Chief Product Officer Executive Director |
291,368
-58.3%
0.16USD 46,094 |
291,368 -58.3% | 0.16 | USD 46,094 | |
| 2021-12-06 | 2021-12-06 | B Purchase |
CEO, GC and Director Executive Director |
69,767
+2049.0%
0.43USD 30,000 |
69,767 +2049.0% | 0.43 | USD 30,000 | |
| 2021-12-06 | 2021-12-06 | B Purchase |
CFO Officer |
36,765
+40.5%
0.44USD 16,177 |
36,765 +40.5% | 0.44 | USD 16,177 | |
| 2021-12-07 | 2021-12-03 | B Purchase |
Chief Product Officer Officer |
101,650
+25.5%
0.46USD 47,013 |
101,650 +25.5% | 0.46 | USD 47,013 | |
| 2021-12-07 | 2021-12-03 | B Purchase |
President, DERMAdoctor, LLC Officer |
101,650
+25.5%
0.46USD 47,013 |
101,650 +25.5% | 0.46 | USD 47,013 | |
| 2021-12-06 | 2021-12-03 | B Purchase |
CFO Officer |
8,690
+10.6%
0.44USD 3,824 |
8,690 +10.6% | 0.44 | USD 3,824 | |
| 2021-12-06 | 2021-12-02 | B Purchase |
Chief Product Officer Officer |
262,369
+192.9%
0.48USD 124,888 |
262,369 +192.9% | 0.48 | USD 124,888 | |
| 2021-12-06 | 2021-12-02 | B Purchase |
President, DERMAdoctor, LLC Officer |
262,369
+192.9%
0.48USD 124,888 |
262,369 +192.9% | 0.48 | USD 124,888 | |
| 2021-12-03 | 2021-12-01 | B Purchase |
Chief Product Officer Officer |
14,848
+12.3%
0.49USD 7,276 |
14,848 +12.3% | 0.49 | USD 7,276 | |
| 2021-12-03 | 2021-12-01 | B Purchase |
President, DERMAdoctor, LLC Officer |
14,848
+12.3%
0.49USD 7,276 |
14,848 +12.3% | 0.49 | USD 7,276 | |
| 2021-12-02 | 2021-11-30 | B Purchase |
Chief Product Officer Officer |
30,000
+32.9%
0.46USD 13,800 |
30,000 +32.9% | 0.46 | USD 13,800 | |
| 2021-12-02 | 2021-11-30 | B Purchase |
President, DERMAdoctor, LLC Officer |
30,000
+32.9%
0.46USD 13,800 |
30,000 +32.9% | 0.46 | USD 13,800 | |
| 2021-11-24 | 2021-11-23 | B Purchase |
President, DERMAdoctor, LLC Officer |
66,133
+264.5%
0.46USD 30,368 |
66,133 +264.5% | 0.46 | USD 30,368 | |
| 2021-11-24 | 2021-11-23 | B Purchase |
Chief Product Officer Officer |
66,133
+264.5%
0.46USD 30,368 |
66,133 +264.5% | 0.46 | USD 30,368 | |
| 2021-11-24 | 2021-11-22 | B Purchase |
President, DERMAdoctor, LLC Officer |
25,000
+inf%
0.46USD 11,500 |
25,000 +inf% | 0.46 | USD 11,500 | |
| 2021-11-24 | 2021-11-22 | B Purchase |
Chief Product Officer Officer |
25,000
+inf%
0.46USD 11,500 |
25,000 +inf% | 0.46 | USD 11,500 | |
| 2020-08-19 | 2020-08-17 | S Sale | Non-Executive Director |
20,000
-100.0%
1.35USD 27,000 |
20,000 -100.0% | 1.35 | USD 27,000 | |
| 2020-08-04 | 2020-08-01 | S Sale | Large shareholder |
1,302,350
-24.6%
1.23USD 1,601,891 |
1,302,350 -24.6% | 1.23 | USD 1,601,891 | |
| 2019-06-13 | 2019-06-11 | S Sale |
15,873
-100.0%
4.04USD 64,127 |
15,873 -100.0% | 4.04 | USD 64,127 | ||
| 2019-06-13 | 2019-06-11 | S Sale | Large shareholder |
380,954
-6.7%
3.84USD 1,462,863 |
380,954 -6.7% | 3.84 | USD 1,462,863 | |
| 2019-06-13 | 2019-06-11 | S Sale |
Pioneer Pharma (Hong Kong) Co Ltd Large shareholder |
24,326
-0.5%
4.04USD 98,277 |
24,326 -0.5% | 4.04 | USD 98,277 | |
| 2019-06-13 | 2019-06-10 | S Sale |
47,619
-100.0%
2.03USD 96,667 |
47,619 -100.0% | 2.03 | USD 96,667 | ||
| 2015-08-21 | 2015-08-20 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
6,000
+100.0%
0.44USD 2,640 |
6,000 +100.0% | 0.44 | USD 2,640 | |
| 2015-08-21 | 2015-08-19 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
6,000
+inf%
0.50USD 3,000 |
6,000 +inf% | 0.50 | USD 3,000 | |
| 2015-03-05 | 2015-03-03 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
166,666
+5.2%
0.60USD 100,000 |
166,666 +5.2% | 0.60 | USD 100,000 | |
| 2015-03-05 | 2015-03-03 | B Purchase |
Pioneer Pharma (Singapore) Pte. Ltd. Large shareholder |
2,590,000
+37.0%
0.60USD 1,554,000 |
2,590,000 +37.0% | 0.60 | USD 1,554,000 | |
| 2015-03-05 | 2015-03-03 | B Purchase |
SIECZKAREK MARK M Non-Executive Director |
166,666
+559.3%
0.60USD 100,000 |
166,666 +559.3% | 0.60 | USD 100,000 | |
| 2014-12-16 | 2014-12-12 | B Purchase |
Stroman David W. SVP, Ophthalmic Product Devt. Officer |
10,000
+76.9%
0.66USD 6,600 |
10,000 +76.9% | 0.66 | USD 6,600 | |
| 2014-12-15 | 2014-12-12 | B Purchase |
PAULSON THOMAS J CFO Officer |
10,000
+17.2%
0.68USD 6,800 |
10,000 +17.2% | 0.68 | USD 6,800 | |
| 2014-12-15 | 2014-12-12 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
50,000
0.65USD 32,500 |
50,000 | 0.65 | USD 32,500 | |
| 2014-12-11 | 2014-12-11 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
20,000
+0.6%
0.60USD 12,000 |
20,000 +0.6% | 0.60 | USD 12,000 | |
| 2014-12-11 | 2014-12-09 | B Purchase |
PAULSON THOMAS J CFO Officer |
10,000
+20.7%
0.67USD 6,700 |
10,000 +20.7% | 0.67 | USD 6,700 | |
| 2014-12-08 | 2014-12-05 | B Purchase |
Najafi Ramin Chief Executive Officer Executive Director Large shareholder |
25,000
+0.8%
0.65USD 16,250 |
25,000 +0.8% | 0.65 | USD 16,250 |